Navigation Links
CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Decrease Pancreatic Cancer Tumor Blood Flow and Reduce Blood Vessel Density
Date:6/23/2011

CFAK-C4, reduced tumor growth in vivo in mouse pancreatic cancer cells by up to 60 percent, and CFAK-C4 combined with chemotherapy drug gemcitabine had a synergistic effect and led to 80 percent pancreatic cancer tumor reduction.  

The study also found that CFAK-C4 combined with gemcitabine had a prolonged effect on pancreatic tumor growth.  Two weeks after treatment, the tumor size in the previously treated group was approximately 75 percent smaller than the tumor in the control group. The researchers concluded that targeting FAK with small molecule inhibitors can be effectively used to develop potential oral-based cancer therapies.

"We continue to gain knowledge about the activity of our lead compound, CFAK-C4, and this most recent study furthers our understanding of FAK inhibitors and the potential of this compound," said H. Shep Wild, President and Chief Executive Officer of CureFAKtor Pharmaceuticals.  "CureFAKtor's proprietary FAK technology platform may represent a significant breakthrough in the treatment of most solid tumor cancers in that its unique mechanism of action disrupts the signaling of specific protein to protein binding between FAK and tumors."

Earlier this year, CureFAKtor received Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for CFAK-C4 in combination with gemcitabine for the treatment of pancreatic cancer, a disease with the lowest survival rate of any cancer and limited patient treatment options.

About Focal Adhesion Kinase (FAK)

Focal adhesion Kinase (FAK) is substantially over-expressed in many solid tumors. FAK operates by placing itself at the contact points between tumor cells and the extra cellular matrix that surrounds them. Studies by CureFAKtor and others found that in this role, FAK is an important facilitator for signals that cause tumor cells to survive, grow, and produce new blood vessels to sustain growth and travel to distant places wit
'/>"/>

SOURCE CureFAKtor Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth
2. CureFAKtor Pharmaceuticals Receives Orphan Drug Designation for Its Lead Compound CFAK-C4 for the Treatment of Pancreatic Cancer
3. MAP Pharmaceuticals to Present Data on LEVADEX® at the 15th Congress of the International Headache Society
4. Radient Pharmaceuticals Corporation Joins OTCQX
5. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
6. Cempra Pharmaceuticals to Present at the 2011 Wells Fargo Healthcare Conference
7. Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6
8. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
9. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
10. Access Pharmaceuticals Receives Letter of Acceptance For MuGard Filing From SFDA of China
11. Cubist Pharmaceuticals Applauds Congressman Gingrey for Introducing Legislation to Help Fight Superbug Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014  There is ... chain organization,s success. The 10th Annual Institute for ... Awards for Excellence in Supply Management is open ... further the understanding and importance of supply management ... leadership and best supply management practices.  Entries are ...
(Date:7/30/2014)... -- CryoLife, Inc. (NYSE: CRY), a leading medical device ... surgery, announced today that its Board of Directors has ... 2014 of $0.03 per share of common stock outstanding.  ... be paid on September 19, 2014 to all common ... ex-dividend date for the quarterly dividend is September 10, ...
(Date:7/30/2014)... 2014 PuraMed BioScience ® , Inc., ... (OTC) medicinal and healthcare products, announced today that ... along with the name,s red and yellow logo. ... name MigraPure ®  going forward. The new ... natural migraine pain reliever will be reintroduced into ...
Breaking Medicine Technology:Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 3PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3
... Cyberonics, Inc. (Nasdaq: CYBX ), a global ... ended January 28, 2011.   Quarterly HighlightsOperating ... compared to the third quarter of fiscal 2010 include: ... U.S. net sales increased by 24%; U.S. epilepsy unit ...
... 1, 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ... that Valeant Pharmaceuticals International ("Valeant"), its wholly owned indirect ... principal amount of senior unsecured notes (the "Notes"). ... Securities Act of 1933, as amended (the "Securities Act"), ...
Cached Medicine Technology:Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance 2Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance 3Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance 4Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance 5Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance 6Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance 7Valeant Launches Senior Notes Offering 2Valeant Launches Senior Notes Offering 3
(Date:7/30/2014)... returning National Guard soldiers were more likely to ... life setbacks, including job loss, legal problems, divorce, ... military families. Results of the study by researchers ... are published online in the American Journal ... a major concern for reservists returning home. Nearly ...
(Date:7/30/2014)... combined immunodeficiency (SCID) can be successfully treated with a ... by Memorial Sloan Kettering,s Richard J. O,Reilly, MD, a ... review will be published in the July 30 issue ... , SCID is a group of inherited disorders that ... breakdown occurs, babies no longer have the ability to ...
(Date:7/30/2014)... Daily Gossip indicates in its 60 Second Panic ... attack is a feeling of intense stress and fear, which ... of symptoms that sufferers commonly deal with when panic attacks ... or anxiety. Naturally, panic attacks deeply affect lifestyle; this is ... them. , The 60 Second Panic Solution review promises to ...
(Date:7/30/2014)... DC and Malaysia (PRWEB) July 30, 2014 ... lives through education by LTT Global an award winning ... pioneering learning on the go since 2004. , MyMobileUni.com’s ... and quality learning content. MMU has links to ... universities, organizations, NGOs’ and subject matter experts from all ...
(Date:7/30/2014)... Washington, DC (PRWEB) July 30, 2014 ... PhD, RN, CNE, ANEF, who since September 2013 has ... Nursing , became the new dean of the College ... 14. The move marries her leadership of the NLN, ... one of the top-ranked academic nursing and research institutions ...
Breaking Medicine News(10 mins):Health News:Vets' alcohol problems linked to stress on the home front 2Health News:Transplantation shown to be highly effective in treating immune deficiency in children 2Health News:60 Second Panic Solution Review Reveals Unique Way to Stop Panic Attacks 2Health News:MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors 2Health News:MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors 3Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 2Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 3
... experimenting. Sometimes that means trying some risky behaviors. ... to cocaine, will be studied in their adolescent years. ... to using drugs, having sex or engaging in delinquent behaviors, ... exposure. The study will also closely follow the ...
... A study by researchers at the University of Leicester ... has hidden biases. Writing in the prestigious British ... how to spot ,publication bias, in the reporting of ... and NHS health policies. They also show what mathematical ...
... is an uncommon chronic liver disease characterized by progressive ... disease progresses slowly, usually leading to biliary cirrhosis, portal ... PSC is a common cause of adult cholestatic ... the liver transplantations in U.S. adults. At least ...
... , Editorial is a Call to Action for ... indicates that the social stigma that surrounds lesbian, gay, bisexual, and transgender ... use, risky sexual behaviors, eating disorders, suicidal ideation, and victimization. An editorial ... calls on clinicians and health researchers to lead the charge in improving ...
... CARDIFF, Calif., Aug.19 Rapi d ... plans to provide services to the medical cannabis industry. With ... the state of California, Rapid Fire Marketing has entered the ... to this newly-emerged industry, which includes medical doctors and cannabis ...
... , , NOVATO, Calif., Aug. ... today that data from clinical studies of Kuvan(R) (sapropterin dihydrochloride) and ... the International Congress of Inborn Errors of Metabolism (ICIEM) in San ... "We look forward to a number of abstracts, posters ...
Cached Medicine News:Health News:Longitudinal study investigates cocaine's impact on adolescent development 2Health News:Study finds adverse effects in treatment for primary sclerosing cholangitis 2Health News:Confronting Health Disparities Among Lesbian, Gay, Bisexual and Transgender Youth 2Health News:Confronting Health Disparities Among Lesbian, Gay, Bisexual and Transgender Youth 3Health News:Rapid Fire Marketing Enters Medical Cannabis Business 2Health News:Rapid Fire Marketing Enters Medical Cannabis Business 3Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 2Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 3Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 4Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 5Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 6
Desmarres Lid Retractor thin solid blades. Size 2....
... system introduces a new level ... microsurgical instrumentation. It has an ... with advanced microcomputer control of ... operate with a full range ...
Multiple Modulation Phaco (MMP) programmability with eight surgeon settings for maximum versatility. The combination of the peristaltic power balanced pump and the piezoelectric handpiece results in ...
... is a unique combination of Paradigm's ... flexibility for modular hardware modifications and ... of changing cataract surgical techniques and ... ophthalmic surgical platforms providing open architecture ...
Medicine Products: